Trillium’s two lead molecules, TTI-622 and TTI-621, block signalling proteins involved in blood cancers, and are both in human trials across several types of disease.
from Sydney Morning Herald - Latest News
Read More
Subscribe to:
Post Comments (Atom)
Most viewed post
-
A senior Iranian lawmaker has warned about the US plan to sell nuclear power plants to Saudi Arabia, suggesting that the Israeli regime coul...
-
PENCIL SKETCH " A sketch a day keeps the dullness away. " This I made with graphite pencils for my stu...
No comments:
Post a Comment
Thank You for sharing your views. I hope you like the arts posted.